DE1411025U - - Google Patents

Info

Publication number
DE1411025U
DE1411025U DENDAT1411025D DE1411025DU DE1411025U DE 1411025 U DE1411025 U DE 1411025U DE NDAT1411025 D DENDAT1411025 D DE NDAT1411025D DE 1411025D U DE1411025D U DE 1411025DU DE 1411025 U DE1411025 U DE 1411025U
Authority
DE
Germany
Prior art keywords
quot
lfr1í
prr
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DENDAT1411025D
Other languages
German (de)
English (en)
Publication of DE1411025U publication Critical patent/DE1411025U/de
Active legal-status Critical Current

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DENDAT1411025D Active DE1411025U (enExample)

Publications (1)

Publication Number Publication Date
DE1411025U true DE1411025U (enExample)

Family

ID=721444

Family Applications (1)

Application Number Title Priority Date Filing Date
DENDAT1411025D Active DE1411025U (enExample)

Country Status (1)

Country Link
DE (1) DE1411025U (enExample)

Similar Documents

Publication Publication Date Title
Donis et al. Distinct lineages of influenza virus H4 hemagglutinin genes in different regions of the world
Greck et al. Electrophilic amination: New synthetic applications
ES2115732T5 (es) Inhibidor tumoral tetrapeptidico que incluye en su estructura fenetilamidas modificadas.
US20020037860A1 (en) Method for reducing or preventing the establishment, growth or metastasis of cancer by administering indazole peptidomimetics PAR-1 antagonist and optionally PAR-2 antagonists
HUT63173A (en) Process for producing oligonucleotide analogs and pharmaceutical compositions comprising same as active ingredient
Locke et al. Newcastle disease virus phosphoprotein gene analysis and transcriptional editing in avian cells
BR0211612A (pt) Cristais que incluem um sal de ácido málico de n-[2-(dietilamino)etil]-5-[(5-flúor2-oxo-3h-indol-3-ilide no)metil]-2,4-dimetil-1h-pirrol-3-carboxamida, processos para a sua preparação e suas composições
EP1218403A2 (en) Combinatorial synthesis of libraries of macrocyclic compounds useful in drug discovery
HU205146B (en) Process for producing teicoplanine amide derivatives and pharmaceutical compositions comprising same
AR018501A1 (es) Derivados de la dolastatina 15
JP2022040131A5 (enExample)
DE60132177T2 (de) Aminosäure-derivate als hiv aspartyl-protease-inhibitoren
YU22496A (sh) Ciklični peptidni antigljivični agensi, njihove farmaceutske formulacije i postupak za dobijanje
Cabre et al. New experimental strategies in amide synthesis using N, N-bis [2-oxo-3-oxazolidinyl] phosphorodiamidic chloride
EP0437729A2 (de) Neue Peptide, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel, insbesondere als Arzneimittel gegen Retroviren
JP2001524083A (ja) テイコプラニン誘導体
CY1105796T1 (el) Θepαπεια οξεωσης της μεγαλης κοιλιας των μηρυκαστικων με αναστολεις αλφα-αμυλασης
Lin et al. Solid-phase synthesis of peptidomimetic oligomers with a phosphodiester backbone
HILL et al. Synthetic DNA probes for the identification of sibling species in the Anopheles gambiae complex
Toda et al. Regional and species differences in the response of isolated arteries to angiotensin II
Awata et al. Assignment of the tenascin gene (HXB) to swine chromosome 1q21. 1→ q21. 3 by fluorescence in situ hybridization
EE05090B1 (et) Tsklipostiinihend kasutamiseks diabeedivastase ravimina, seda sisaldav farmatseutiline preparaat,hendi ja preparaadi valmistamine ning selleks vajalik mikroorganism
EP0094815A2 (en) Oligopeptide prodrugs
NO860624L (no) Acylerte heksosederivater og fremgangsmaater til fremstilling derav.
CN101111475B (zh) 抗病毒化合物及方法